Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TEN ALLIED, First Half Ordinary Profit Turns to Loss, Jul-Sep Ordinary Profit Turns to Loss
8207 TEN ALLIED CO.,LTD. 【J-GAAP】
Earnings ReportTEN ALLIED CO.,LTD. <8207> [TSE Std] announced its financial results after the market closed on November 7th (15:30). The consolidated ordinary profit/loss for the cumulative second quarter of the fiscal year ending March 2026 (April to September) turned into a loss of 24 million yen (compared to a profit of 102 million yen in the same period last year).
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to significant drop 78.0% from the same period last year to 28 million yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit/loss turned to a loss of 54 million yen (compared to a profit of 28 million yen in the same period last year). The operating profit/loss margin worsened from 0.9% in the same period last year to -1.7%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2023 | 5,451 | -10 | -3 | -32 | -1.0 | ー | Nov 13, 2023 | J-GAAP |
| Apr - Sep, 2024 | 5,858 | 98 | 102 | 69 | 1.9 | 44.5 | Nov 8, 2024 | J-GAAP |
| Apr - Sep, 2025 | 6,008 | -26 | -24 | -67 | -1.7 | ー | Nov 7, 2025 | J-GAAP |
| YoY | +2.6% | - | - | - | - |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | 6,008 | -26 | -24 | -67 | -1.7 | 0 | Nov 6, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 6,008 | -26 | -24 | -67 | -1.7 | 0 | Nov 7, 2025 | J-GAAP |
| Revision Rate | 0.0% | 0.0% | 0.0% | 0.0% | -1.2% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 6,029 | 134 | 127 | 76 | 2.1 | 0 | May 9, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 6,207 | 34 | 28 | -200 | -5.0 | 0 | Nov 6, 2025 | J-GAAP |
| YoY | +3.0% | -74.6% | -78.0% | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 11,146 | 168 | 170 | 27 | 0.8 | 0 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 11,887 | 232 | 229 | 145 | 3.9 | 0 | May 9, 2025 | J-GAAP |
| Mar, 2026 Guidance | 12,215 | 8 | 4 | -267 | -6.7 | 0 | Nov 6, 2025 | J-GAAP |
| YoY | +2.8% | -96.6% | -98.3% | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 2,907 | 27 | 28 | 10 | 0.3 | 0.9 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 3,041 | 121 | 126 | 111 | 3.0 | 4.0 | Feb 7, 2025 | J-GAAP |
| Jan - Mar, 2025 | 2,988 | 13 | 1 | -35 | -0.9 | 0.4 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 3,040 | 24 | 30 | 0 | 0.0 | 0.8 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 2,968 | -50 | -54 | -67 | -1.7 | -1.7 | Nov 7, 2025 | J-GAAP |
| YoY | +2.1% | - | - | - | - |
Related Articles
CL Holdings, Jan-Sep (Cumulative 3Q) Net Income Increases by 98%, Jul-Sep Net Income Increases by 2.9 times
TAKAMISAWA, Jul-Sep (1Q) Ordinary Profit Decreases by 54%
SAPPORO CLINICAL LAB, First Half Ordinary Profit Increases by 13%, Jul-Sep Ordinary Profit Increases by 23%
Oenon Holdings, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 50%, Jul-Sep Ordinary Profit Increases by 85%
Paraca, 3% Increase in Ordinary Profit, Update Record High for Fourth Consecutive Term, Dividend Raised by 3 Yen
Nippon Information Development, First Half Ordinary Profit Decreases by 9%, Jul-Sep Ordinary Profit Decreases by 7%
Techno Medica, Jul-Sep (2Q) Ordinary Profit Increases by 6.3 times
CHOFU SEISAKUSHO, Jan-Sep (Cumulative 3Q) Ordinary Profit Decreases by 3%, Jul-Sep Ordinary Profit Decreases by 19%
MT GENEX, First Half Ordinary Profit Decreases by 4%, Jul-Sep Ordinary Profit Decreases by 14%
OKANO VALVE MFG, Ordinary Profit for The Current Fiscal Year, with a Change in the Fiscal Year-End, is 1.0 Billion Yen